Financials
- Market Capitalization 2.08 B
- Employee 1 605
- Founded 2000
- CEO Asaf Danziger
- Website www.novocure.com
- Headquarter N/A
- FIGI N/A
- Industry Medical Devices
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1932 | BFLY Butterfly Network, Inc. Class A Common Stock | 8.43 USD | -3.44% | -9.65% | +18.57% | +443.87% | 2.24 B USD | ||
| 1969 | ESTA Establishment Labs Holdings Inc. - Common Shares | 70.64 USD | -1.62% | -2.98% | -24.63% | +42.25% | 2.11 B USD | ||
| 2094 | INSP Inspire Medical Systems, Inc. Common Stock | 61.39 USD | +0.92% | -1.60% | +22.78% | -21.76% | 1.77 B USD | ||
| 2190 | CNMD CONMED Corporation Common Stock | 50.06 USD | -0.54% | -1.65% | +8.00% | +4.40% | 1.50 B USD |
Frequently asked questions about NovoCure Limited Ordinary Shares
What is the NovoCure Limited Ordinary Shares stock price today?
The current price of NovoCure Limited Ordinary Shares (NVCR) is 17.82. Over the past 24 hours, the stock has changed by -0.94%. Follow the NVCR chart for real-time price dynamics.
What is the stock ticker of NovoCure Limited Ordinary Shares?
NovoCure Limited Ordinary Shares trades under the ticker NVCR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is NovoCure Limited Ordinary Shares stock going up?
NVCR has changed by +4.45% over the last week, +17.31% over the last month, and +29.60% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of NovoCure Limited Ordinary Shares?
NovoCure Limited Ordinary Shares currently has a market capitalization of 2.08 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were NovoCure Limited Ordinary Shares earnings last quarter?
Last quarter, NovoCure Limited Ordinary Shares reported earnings of -0.13 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was NovoCure Limited Ordinary Shares revenue for the last quarter?
NovoCure Limited Ordinary Shares reported quarterly revenue of 183.58 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was NovoCure Limited Ordinary Shares net income for the last quarter?
NovoCure Limited Ordinary Shares reported net income of -15.66 M for the last quarter. The previous quarter showed -71.14 M, which means net income changed by +77.99%.
How many employees does NovoCure Limited Ordinary Shares have?
As of the latest available data, NovoCure Limited Ordinary Shares has 1 605 employees. Workforce size can provide additional context about the company's scale and operations.
What is NovoCure Limited Ordinary Shares EBITDA?
NovoCure Limited Ordinary Shares EBITDA is -13.15 M, and its EBITDA margin is -7.17%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy NovoCure Limited Ordinary Shares stock?
You can buy NovoCure Limited Ordinary Shares (NVCR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in NovoCure Limited Ordinary Shares stock?
Investing in NovoCure Limited Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NVCR chart and related analysis on metatrader.com as part of your research.